IMMUNITYBIO, INC. Investment Income, Interest
IMMUNITYBIO, INC. (IBRX) reported Investment Income, Interest of $339.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-05-14
- IMMUNITYBIO, INC. investment income, interest for the quarter ending 2021-03-31 was $339.00K, a 5.28% increase year-over-year.
- IMMUNITYBIO, INC. investment income, interest for the quarter ending 2020-12-31 was $930.00K, a 35.37% decline year-over-year.
- IMMUNITYBIO, INC. investment income, interest for the quarter ending 2020-09-30 was $449.00K, a 5.90% increase year-over-year.
- IMMUNITYBIO, INC. investment income, interest for the quarter ending 2020-06-30 was $122.00K, a 75.15% decline year-over-year.
- IMMUNITYBIO, INC. investment income, interest for fiscal 2018 was $2.32M, a 45.16% decline from fiscal 2017.
- IMMUNITYBIO, INC. investment income, interest for fiscal 2017 was $4.22M, a 18.25% decline from fiscal 2016.
- IMMUNITYBIO, INC. investment income, interest for fiscal 2016 was $5.17M, a 1556.41% increase from fiscal 2015.
- IMMUNITYBIO, INC. investment income, interest for fiscal 2015 was $312.00K, a 1460.00% increase from fiscal 2014.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-03-31 | $339.00K 10-Q · filed 2021-05-14 | $1.27M derived: sum of 2 quarters · filed 2021-05-14 | $1.72M derived: sum of 3 quarters · filed 2021-05-14 | $1.84M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2020-12-31 | $930.00K derived: 8-K/A 12 month − 10-Q 9 month · filed 2021-04-22 | $1.38M derived: sum of 2 quarters · filed 2021-04-22 | $1.50M derived: sum of 3 quarters · filed 2021-04-22 | $1.73M 8-K/A · filed 2021-04-22 | $1.23M 10-K · filed 2021-03-04 | |
| 2020-09-30 | $449.00K 10-Q · filed 2020-11-09 | $571.00K derived: sum of 2 quarters · filed 2020-11-09 | $795.00K 10-Q · filed 2020-11-09 | $2.33M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2020-06-30 | $122.00K 10-Q · filed 2020-08-07 | $346.00K 10-Q · filed 2020-08-07 | $1.88M derived: sum of 3 quarters · filed 2021-05-14 | $2.31M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2020-03-31 | $322.00K 10-Q · filed 2021-05-14 | $224.00K 10-Q · filed 2020-05-11 | $1.76M derived: sum of 2 quarters · filed 2021-05-14 | $2.19M derived: sum of 3 quarters · filed 2021-05-14 | $2.68M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $1.44M derived: 8-K/A 12 month − 10-Q 9 month · filed 2021-04-22 | $1.86M derived: sum of 2 quarters · filed 2021-04-22 | $2.35M derived: sum of 3 quarters · filed 2021-04-22 | $2.76M 8-K/A · filed 2021-04-22 | $1.64M 10-K · filed 2020-03-25 | |
| 2019-09-30 | $424.00K 10-Q · filed 2020-11-09 | $915.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.32M 10-Q · filed 2020-11-09 | $1.82M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-06-30 | $491.00K 10-Q · filed 2020-08-07 | $901.00K 10-Q · filed 2020-08-07 | $1.40M derived: sum of 3 quarters · filed 2021-03-04 | $1.88M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-03-31 | $410.00K 10-Q · filed 2020-05-11 | $905.00K derived: sum of 2 quarters · filed 2021-03-04 | $1.39M derived: sum of 3 quarters · filed 2021-03-04 | $2.02M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2018-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $981.00K derived: sum of 2 quarters · filed 2021-03-04 | $1.61M derived: sum of 3 quarters · filed 2021-03-04 | $2.32M 10-K · filed 2021-03-04 | ||
| 2018-09-30 | $486.00K 10-Q · filed 2019-11-05 | $1.12M derived: sum of 2 quarters · filed 2019-11-05 | $1.82M 10-Q · filed 2019-11-05 | $2.64M derived: sum of 4 quarters · filed 2020-03-25 | ||
| 2018-06-30 | $632.00K 10-Q · filed 2019-08-06 | $1.34M 10-Q · filed 2019-08-06 | $2.15M derived: sum of 3 quarters · filed 2020-03-25 | $3.16M derived: sum of 4 quarters · filed 2020-03-25 | ||
| 2018-03-31 | $704.00K 10-Q · filed 2019-05-08 | $1.52M derived: sum of 2 quarters · filed 2020-03-25 | $2.53M derived: sum of 3 quarters · filed 2020-03-25 | $3.58M derived: sum of 4 quarters · filed 2020-03-25 | ||
| 2017-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $1.82M derived: sum of 2 quarters · filed 2020-03-25 | $2.87M derived: sum of 3 quarters · filed 2020-03-25 | $4.22M 10-K · filed 2020-03-25 | ||
| 2017-09-30 | $1.00M 10-Q · filed 2018-11-07 | $2.05M derived: sum of 2 quarters · filed 2018-11-07 | $3.41M 10-Q · filed 2018-11-07 | $4.77M derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2017-06-30 | $1.05M 10-Q · filed 2018-08-06 | $2.40M 10-Q · filed 2018-08-06 | $3.77M derived: sum of 3 quarters · filed 2019-03-13 | $5.14M derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2017-03-31 | $1.35M 10-Q · filed 2018-05-07 | $2.72M derived: sum of 2 quarters · filed 2019-03-13 | $4.09M derived: sum of 3 quarters · filed 2019-03-13 | $5.33M derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2016-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $2.74M derived: sum of 2 quarters · filed 2019-03-13 | $3.98M derived: sum of 3 quarters · filed 2019-03-13 | $5.17M 10-K · filed 2019-03-13 | ||
| 2016-09-30 | $1.37M 10-Q · filed 2017-11-07 | $2.61M derived: sum of 2 quarters · filed 2017-11-07 | $3.80M 10-Q · filed 2017-11-07 | $3.97M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | $1.24M 10-Q · filed 2017-08-07 | $2.43M 10-Q · filed 2017-08-07 | $2.60M derived: sum of 3 quarters · filed 2018-03-12 | $2.68M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-03-31 | $1.19M 10-Q · filed 2017-05-08 | $1.36M derived: sum of 2 quarters · filed 2018-03-12 | $1.44M derived: sum of 3 quarters · filed 2018-03-12 | $1.47M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2015-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $247.00K derived: sum of 2 quarters · filed 2018-03-12 | $280.00K derived: sum of 3 quarters · filed 2018-03-12 | $312.00K 10-K · filed 2018-03-12 | ||
| 2015-09-30 | $81.00K 10-Q · filed 2016-11-10 | $114.00K derived: sum of 2 quarters · filed 2016-11-10 | $146.00K 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | $33.00K 10-Q · filed 2016-08-15 | $65.00K 10-Q · filed 2016-08-15 | ||||
| 2015-03-31 | $32.00K 10-Q · filed 2016-05-16 | |||||
| 2014-12-31 | $20.00K 10-K · filed 2017-03-15 | |||||
| 2013-12-31 | $2.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |